You just read:

AbbVie and Bristol-Myers Squibb Announce Oncology Clinical Collaboration to Evaluate the Combination of Rova-T plus Opdivo and Opdivo + Yervoy Regimen

News provided by

AbbVie

Jul 25, 2016, 06:59 ET